-
A large cohort study in Denmark showed that patients with a previous myocardial infarction (MI) who took any NSAID had an increased risk of death or a recurrent MI. The greater the use of an NSAID, the greater the risk.
-
With Medicare's new value-based purchasing (VBP) program set to begin impacting payments to most acute-care hospitals in October 2012, providers have been put on notice that the fee-for-service payment methodology is being gradually replaced by payment formulas that reward quality.
-
In 2008, there was plenty of evidence that things weren't working very well in the ED at St. Vincent's Medical Center in Bridgeport, CT. The leave-without-being-seen (LWBS) rate was at 5%, the average wait time to see a physician was over two hours, patient satisfaction was in the single digits, and the hospital recorded eight serious safety events in that one year alone.
-
-
What will it take to drive down the number of chlamydia infections in young women? While routine chlamydia screening is recommended for all sexually active females age 24 years and younger, only about half (49.9%) were screened during 2008-09, according to data collected in more than 1,000 U.S. health plans.
-
For four decades, safety-net providers such as community health centers have turned to the National Health Service Corps (NHSC) for help with maintaining a well-trained and credentialed workforce.
-
One woman in five develops a urinary tract infection (UTI) during her lifetime, according to the National Institute of Diabetes and Digestive and Kidney Diseases.
-
Add another human papillomavirus (HPV) test to the clinical arsenal. The Food and Drug Administration (FDA) has approved the Roche cobas HPV Test.
-
A just-published study indicates that many providers are failing to counsel women on the availability of emergency contraception (EC).
-
Results of two case-control studies indicate that women without risk factors for venous thromboembolism (VTE) who use oral contraceptives (OCs) containing drospirenone have an increased risk for nonfatal VTE compared with those who use levonorgestrel OCs.